English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Corporate social responsibility (CSR) is discussed, targeting a broad range of industries. As yet, little work on CSR has focused on the specific situation of each industry. The biotechnology industry is unique in that companies use the genes and genomes of plants, animals, and humans, as well as biotechnology in their business. Public concern about genes and genomes centres on their inappropriate use or application in either research or business. This paper proposes a new CSR component for biotechnology companies: taking responsibility for the use of genes, genomes, and biotechnology (GGB) by adopting environmental ethics and bioethics. Environmental ethics is proposed as the ethical root of the environmental responsibility that companies take. The principles of environmental ethics are inductively reasoned from actual business activities, and towards the achievement of environmental responsibility. CSR for the use of GGB is deductively derived from the principles of bioethics and genetic ethics.

Social responsibility for the use of genes, genomes and biotechnology in biotechnology companies: A commentary from the bioethical viewpoint